-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

BRIEF-Aeglea Biotherapeutics Announces Update To Corporate Structure

Reuters · 01/06/2023 07:11
BRIEF-Aeglea Biotherapeutics Announces Update To Corporate Structure

- Aeglea Bio Therapeutics Inc AGLE.O:

  • AEGLEA BIOTHERAPEUTICS ANNOUNCES UPDATE TO CORPORATE STRUCTURE TO INCREASE OPERATIONAL EFFICIENCY

  • AEGLEA BIO - STREAMLINING OF ORGANIZATION TO FOCUS ON NEAR-TERM DELIVERABLES FOR PEGTARVILIASE IN HOMOCYSTINURIA AND LONG-TERM VALUE CREATION

  • AEGLEA BIO THERAPEUTICS INC - AS PART OF THESE ADDITIONAL CHANGES, WORKFORCE OF COMPANY HAS BEEN FURTHER REDUCED BY APPROXIMATELY 15%

  • AEGLEA BIO THERAPEUTICS INC - AEGLEA IS ALSO HALTING PRECLINICAL WORK ON CYSTINURIA AND OTHER UNNAMED PIPELINE PROGRAMS

  • AEGLEA BIO THERAPEUTICS INC - WILL EVALUATE POTENTIAL STRATEGIC OPTIONS FOR THESE PROGRAMS IN ORDER TO MAXIMIZE VALUE

  • AEGLEA BIO - CORTNEY CAUDILL HAS BEEN PROMOTED FROM SENIOR VICE PRESIDENT OF TECHNICAL OPERATIONS TO CHIEF PRODUCT OFFICER, EFFECTIVE JANUARY 6

  • AEGLEA BIO THERAPEUTICS INC - THE CHANGES ARE IN ADDITION TO RESTRUCTURING PROCESS THAT WAS INITIATED IN AUGUST 2022

Source text for Eikon: ID:

Further company coverage: AGLE.O


((Reuters.Briefs@thomsonreuters.com;))